PepsMetabolic effects of a growth hormone-releasing factor in patients with HIV.
Human randomized trial · 2007
Metabolic effects of a growth hormone-releasing factor in patients with HIV.
Read profile evidence → · Original publication ↗Tesamorelin + ipamorelin blend
PRODUCT KNOWLEDGE · BioLongevity Labs
A two-component research listing with a declared 6 mg of tesamorelin and 2 mg of ipamorelin.
DECLARED COMPOSITION
8 mg total- Tesamorelin6 mg
- Ipamorelin2 mg
What the supplier lists
Seller describes a lyophilized vial. The composition below is attributed to this listing; it is not an independent measurement.
| Listed ingredient | Declared amount | Identity & research context |
|---|---|---|
| Tesamorelin | 6 mg | Research listing; not interchangeable with a defined prescription product. Tesamorelin research context → |
| Ipamorelin | 2 mg | Named ingredient; individual research is not a trial of this blend. Ipamorelin research context → |
Composition source: Supplier composition and product description ↗ (affiliate link). A shared blend name can refer to different ingredients, ratios, or identities at another supplier.
Identity check
The tesamorelin clinical studies linked from its profile tested their own study preparation. They did not test this supplier's 6:2 research blend with ipamorelin.
Based on Supplier composition and product description ↗ (affiliate link); batch composition has not been independently verified.
Ingredient research and blend evidence
These are selected studies of individual ingredients or related identities. They did not validate the seller's finished blend. Open the linked profile for the population, design, results, and limitations.
Ipamorelin, the first selective growth hormone secretagogue.
Animal / laboratory study · 1998
Ipamorelin, the first selective growth hormone secretagogue.
Read profile evidence → · Original publication ↗Questions an exact-formulation study would need to answer
- Were the same chemical identities and ratio actually tested?
- Was the preparation stable and compatible under the tested conditions?
- Did the full combination improve a measured outcome against an appropriate comparator?
- What adverse effects and interactions were measured, in which population and for how long?
Different ingredients or plausible mechanisms do not establish synergy. A research-use designation is not a finding of clinical safety or efficacy.
Supplier listing and documentation
- Supplier
- BioLongevity Labs
- Listed starting price
- $115.00
- Snapshot availability
- Listed in stock
- Price check
- 2026-10-04
Price and availability are dated listing snapshots. Shipping, taxes, options, and later changes are excluded.
Supplier composition and product description ↗ (affiliate link)
Direct link · No affiliate commission active. Listing inclusion does not verify the product or endorse the supplier.
A product description or general purity claim does not verify every ingredient or ratio in a purchased lot. Match the lot identifier, analytes, methods, and quantitative results to the specific material; a certificate does not establish a clinical outcome.
Continue researching
Browse product knowledge → · Browse supplier catalog →
Educational product reference. No dosing, mixing, or administration instructions are provided. Medical and full-formulation evidence review remain pending.